Scrip Regulatory Affairs
The EU Data Protection Regulation proposed by the European Commission in January will – if adopted in its current form – require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
BNA’s Privacy & Security Law Report
Following meetings held Feb. 24-25, the Council of the European Union released its ‘‘Conclusions’’ in response to the EU Commission’s Nov. 4, 2010 ‘‘Communication’’ proposing ‘‘a comprehensive approach on personal data protection in the European Union.’’ The Council is the main decision-making body of the European Union, comprising the ministers of the Member States. Depending on the issue on the agenda, each country is represented by the minister responsible for that subject (foreign affairs, finance, social affairs, transport, agriculture, etc.).